Cancer Drug Pricing's Game of Chicken: MSKCC Investigators Make a Drug Company Blink

Dr. H. Jack West, medical oncologist from Swedish Cancer Institute in Seattle, WA,  discusses recent developments around pricing and value for Zaltrap (ziv-aflibercept) triggered by a New York Times op-ed piece by MSKCC physicians.